Our original approach to assessment and treatment has shown promising results over the last year. In a recent sample of over 180 (initial follow-up) and 70 (secondary follow-up) patients we saw steady improvement in their depression and anxiety symptoms.
On average we saw a decrease in our initial group's PHQ-9 (depression) screening tool score by over one point and nearly 1.5 points GAD-7 (anxiety) screening tool.
Our secondary follow-up group saw even more improvements in their scores. On average, the group of patients demonstrated close to a two-point decrease in their PHQ-9 (depression) screening tool score and over a two-point decrease in their GAD-7 (anxiety) screening tool score.